Clinical Trial

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 28, 2023 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-21.
Trial Details
NCT Number NCT06057051
Lead Sponsor Glaukos Corporation
Conditions Glaucoma
Enrollment 245 participants
Start Date 2023-09-01
Primary Completion 2025-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2023-09-28